), the first and rate-limiting step of the kynurenine pathway for L-Trp catabolism [1] [2] [3] [4] [5] [6] [7] . Trp is the least abundant essential amino acid. The majority of dietary Trp (~95%) is metabolized in the liver through this pathway to produce NAD + , while a small amount (~1%) is utilized to synthesize serotonin and melatonin through the serotonin pathway. TDO hence plays an important role in controlling the relative Trp flux along the two pathways. Its up-regulation can lead to over-production of neuroactive metabolites as well as serotonin deficiency. In Drosophila, TDO is known as vermilion, responsible for the bright-red eye color, due to its involvement in ommochrome biosynthesis 8 . TDO and IDO have been linked to a variety of human diseases including Alzheimer's, Huntington's, depression-associated anxiety, schizophrenia, and autism [9] [10] [11] [12] [13] [14] [15] [16] . Recently, it was discovered that, in addition to the liver, TDO is highly expressed in certain cancer cells, where it plays a critical role in suppressing anti-tumor immunity via activating the aryl hydrocarbon receptor 17, 18 . These discoveries have triggered a great deal of new interest in targeting TDO and IDO for drug discovery [19] [20] [21] [22] [23] [24] . TDOs are homo-tetrameric enzymes with 35-45 kD monomers and are well conserved from bacteria to humans ( Supplementary Fig. 1 ). In comparison, IDOs are monomeric enzymes and the sequence conservation between TDO and IDO is much weaker, with 16% sequence identity between hTDO and human IDO1 (hIDO1) (Supplementary Fig. 1 ). While the properties of TDO have been studied extensively 1,2 , the detailed dioxygenase mechanism remains poorly understood.
Binding modes of the substrates L-Trp and O 2 . The crystallographic analysis revealed that the active sites of the four subunits of the hTDO tetramer are in different states in terms of the catalytic conversion of L-Trp, giving us several snapshots along the reaction coordinate. Clear electron density was observed for L-Trp and O 2 in subunits A (Fig. 3a) and B, allowing the definition of the relative regioorientation of the two substrates prior to the reaction for the first time. The O 2 substrate is coordinated to the heme iron as the sixth ligand. The Fe-O-O moiety is slightly bent (Fig. 3b) , with a Fe-O-O angle of ~150°. The angle is significantly larger than that expected for a typical ferrous iron bound neutral dioxygen (∠ Fe-O-O = 120°) 30 , consistent with the [Fe 3+ -O 2 − ] electronic configuration revealed by earlier resonance Raman studies 31 . The terminal oxygen atom is situated next to the plane of the L-Trp indole ring, close to its C 2 (2.9 Å distance) and N 1 (2.5 Å) atoms. Intriguingly, the electron density for the terminal oxygen atom is connected to these two atoms of the indole ring in subunit A, although the origin of this connection is not clear and this connection is much weaker in subunit B. We tried different conformational states for L-Trp but none of them could satisfactorily explain the density connecting O 2 to the indole. The terminal oxygen also has strong hydrogen-bonding interactions with the main-chain amide of Gly152 (2.5 Å) in the DE loop (connecting helices α D and α E). This oxygen is 4.4 Å from the main-chain ammonium ion of the L-Trp substrate, although earlier experimental and QM/MM studies suggested that they are within hydrogen-bonding distance [32] [33] [34] . These interactions strategically position O 2 next to L-Trp for the catalysis. The recognition of the L-Trp substrate by hTDO (Fig. 3b ) is similar to that by XcTDO 25 ( Fig. 3c) , as most of the residues in the active site region of the two enzymes are conserved ( Supplementary Fig. 1 ). His76 is hydrogen-bonded to the N 1 atom of L-Trp, although this interaction is not essential for TDO catalysis 35, 36 and this residue is replaced by Ser in IDO ( Supplementary Fig. 1 ). The JK loop, with a β -reverse turn structure at its tip formed by a highly conserved GTGG motif ( Supplementary Fig. 1 ), covers the active site (Fig. 3b) . The hydroxyl group of the Thr side chain in this motif is hydrogen-bonded to the ammonium ion of L-Trp and the main-chain carbonyl oxygen of Ala150, which may also help organize the active site for catalysis.
Binding mode of the product NFK. The electron density in the active site of subunit C (Fig. 4a) and subunit D (Fig. 4b) is consistent with the product NFK, allowing us to define for the first time the binding mode of this product to TDO. The pyrrole ring of the Trp side chain has opened, but good electron density was observed only for the remaining six-membered ring and its N-formyl group, which is coordinated to the heme iron. In contrast, the indole ring of L-Trp does not fit well into the density, and the ring cannot explain the strong density connection to the iron (Fig. 4a,b) . The JK loop is ordered in subunit C but disordered in subunit D (Fig. 4c) . The rest of the structures of the two subunits are similar to each other ( Supplementary Fig. 2 ). The observation that two subunits of the tetramer are trapped in the O 2 and Trp bound state while the other two are in the product-bound Implications for hTDO catalytic mechanism. The crystallographic analyses have allowed us to directly visualize both the substrate and product complexes of hTDO. The structural data, together with earlier spectroscopic and computational studies [31] [32] [33] , support a two-step ferryl-based dioxygenation mechanism (Fig. 5a ). The first step of the reaction is initiated by radical addition of the heme-iron-bound dioxygen to C 2 of L-Trp to generate a ferryl and Trp-epoxide intermediate, via a 2-indolenylperoxo transition state. An alternative, electrophilic addition of O 2 to L-Trp in the first step of the reaction has also been proposed [38] [39] [40] , but QM/MM calculations favor radical addition mechanism [31] [32] [33] . In the second step, protonation of the epoxide by the ammonium ion of L-Trp opens the epoxide ring and triggers the addition of the ferryl-oxygen to C 2 , ultimately leading to the breakage of the C 2 -C 3 bond and the formation of the NFK product. The formyl group of NFK is coordinated to the iron atom Besides the disordering of the JK loop in subunit D, the structures of the four subunits in the immediate active site region are highly similar to each other (Fig. 3d) . On the other hand, large conformational differences in the segment connecting α E and α G (EG segment) are observed in the four subunits (Fig. 3d) . This segment contains a short helix (α F) in subunit A (Fig. 3b) , but is partly disordered in subunits B and C (Fig. 3d) , and is a loop in subunit D (Fig. 4c) , where its conformation is partly stabilized by crystal packing. The Tyr175 side chain in this segment is positioned near the JK loop in subunit A (Fig. 3b) , but in subunit D it would clash with the JK loop if the loop were ordered (Fig. 4c) . In comparison, the EG segment in XcTDO is positioned further away from the active site due to a deletion in this region ( Fig. 3c and Supplementary Fig. 1 ). On the other hand, the EG segment, as well as the JK loop and helix α K are disordered in the apo hTDO structure 28 ( Supplementary Fig. 3 ), due to the absence of the heme and substrates.
To assess the functional importance of the EG segment, we created the Y175G mutant and compared its activity to that of the wild-type (WT) enzyme with stopped-flow measurements (Supplementary Figs 4 and 5). As summarized in Fig. 5 , the mutation led to a 6-fold slower multiple turnover velocity (Fig. 5b) . In addition, pre-incubation of the Y175G mutant with 8 mM NFK retards the formation of the ternary complex by ~100-fold ( Fig. 5c ) and impedes Trp binding (Fig. 5d) . Overall, the data suggest that the EG segment in hTDO plays a critical role in promoting NFK release, thereby allowing Trp binding during multiple turnover. An exo site for L-Trp binding in hTDO. The structure revealed that a second L-Trp molecule is bound to each hTDO subunit, with well-defined electron density (Fig. 6a ). This exo site is located at the other end of the four-helical bundle and is ~42 Å from the active site (Fig. 2a) . The side chain of this L-Trp is sandwiched between Trp208 (helix α H) and Pro213, and is in direct contact with several other hydrophobic residues (Fig. 6b) . The main-chain carboxylate group has bidentate ion-pair interactions with the side chain of Arg211 (α H). The ammonium ion of L-Trp is positioned near the main-chain carbonyl of Arg103 and the side chain of Glu105, which also has ion-pair interactions with Arg303.
Residues forming this novel exo site are well conserved among tryptophan-auxotrophic TDOs, but they are generally poorly conserved in other orthologs ( Supplementary Fig. 1 ). This binding site does not exist in XcTDO, due to side-chain substitutions as well as main-chain conformational differences. Nonetheless, a second binding site for L-Trp was observed in XcTDO at the tetramer interface 25 ( Supplementary Fig. 3 ), while the exo site in hTDO is located within each subunit.
We next carried out isothermal titration calorimetry (ITC) experiments to verify the presence of two L-Trp binding sites in hTDO. Two transitions were observed, corresponding to association constants of 2.06 ± 1.34 × 10 6 M -1 (K d~0 .5 μ M) and 1.84 ± 0.04 × 10 4 M -1 (K d~5 4 μ M) (Fig. 6c) , which we assigned to the exo site and the active site, respectively. To confirm this assignment, we generated a double mutant W208V/R211L (referred to as the WR mutant hereafter) and showed that the mutation abolished the high affinity site without significantly perturbing the low affinity site (Fig. 6d) . Overall, the ITC data revealed that the exo site exhibits 100-fold higher affinity for L-Trp than the active site, and that the WR double mutation is sufficient to disrupt L-Trp binding to the exo site.
We also examined whether the exo site has any effect on the catalytic activity of hTDO. While it might be expected that the exo site can regulate hTDO catalysis indirectly by modulating the organization of the four helical bundle (Fig. 2a) , our kinetic data indicate that a triple mutant, E105L/W208V/R211L (EWR mutant), had only a minor defect in catalysis as compared to the wild-type enzyme (Fig. 6e) .
The exo site regulates hTDO cellular stability. Mouse TDO (mTDO) is one of the most rapidly degraded hepatic proteins, with a half-life (t 1/2 ) of ~2.5 h, versus a mean t 1/2 of ~2-3 days for total liver protein 41 . This unusually short lifespan is consistent with the large number (15) of mTDO ubiquitination sites 42 , which probably enables its rapid removal via ubiquitin (Ub)-dependent proteasomal degradation (UPD). A second Trp-binding site in mTDO was previously proposed based on in vivo and in vitro studies 41 . In addition, it was shown that binding of L-Trp, or its α -methyl analog (α MTrp), to this site not only stabilizes the enzyme against heat, urea or proteases, but also reduces its hepatic degradation.
We hypothesized that the exo site observed in the current hTDO structure is equivalent to the second site functionally identified in mTDO and that binding of L-Trp to the exo site stabilizes hTDO against UPD, thereby regulating its biological lifespan. To test this hypothesis, we first carried out 35 S-pulse-chase analyses of a full-length His 6 -tagged hTDO protein expressed in a human liver HepG2 cell culture. We found that the inclusion of α MTrp, which primarily binds to the exo site (as its α -methyl group has steric clashes with the heme in the active site), in the culture media indeed increased the in vivo t 1/2 of hTDO protein by ~2-fold (from 90 to 172 min), based on total radioactivity (Fig. 7a) as well as SDS-PAGE/fluorographic analyses of the pulled-down parent (47 kD) and ubiquitinated (> 56 kD) hTDO species (Fig. 7b) . In contrast, the EWR mutant was not stabilized by α MTrp, confirming that the stabilization is due to α MTrp binding to the exo site. We used α MTrp rather than L-Trp in these experiments as HepG2 cells require aerobic culture for viability, and exogenous L-Trp is readily consumed by the over-expressed hTDO under these conditions. Marked hTDO stabilization was also observed in HepG2 cells upon inclusion of the proteasomal inhibitor MG132 (10 μ M), thereby attesting to its cellular UPD (data not shown). Together, these data verify that UPD is a major pathway for cellular hTDO disposal and that α MTrp/L-Trp binding to the exo site can enhance its intracellular stability by reducing its UPD.
To identify the hTDO ubiquitination sites, we incubated the enzyme with two E2/E3 Ub-ligase complexes that are major participants in the UPD of some hepatic proteins 43, 44 and identified 15 ubiquitinated Lys residues by Ub-remnant profiling and LC-MS/MS analyses ( Table 2) . While similar proteomic analyses of mouse liver extracts identified ten of these sites in mTDO previously 42 , 5 of the sites identified here (K17, K110, K185, K194 and K259) are entirely new (Table 2 ). In addition, we found that the three E2/E3 complexes have different hTDO-ubiquitination efficiencies: Ubc7/gp78 > UbcH5a/CHIP > Ubc7/Hrd1 (Fig. 7c) .
Molecular recognition of hepatic cytochromes P450 by these E2/E3 Ub-ligases involves electrostatic interactions between positively charged E2/E3-domains and negatively charged surface clusters of phosphorylated Ser/Thr and acidic Asp/Glu-residues. Lys residues within such clusters in P450 were shown to be predominantly targeted for ubiquitination 44 . The 15 hTDO ubiquitination sites are distributed throughout the surface of the monomer (Fig. 7d) and tetramer. Intriguingly, the helix-loop-helix segment of hTDO is rich in negatively-charged Glu residues and 5 of its 15 identified ubiquitination sites are located within this region (Fig. 7d) . Conceivably, this segment is important for the molecular recognition of hTDO by these E2/E3 complexes, and the subsequent ubiquitination of Lys residues in this segment is required for UPD. As the exo site is located close to this helix-loop-helix segment (Fig. 2a) , this offers a plausible molecular mechanism for this site to regulate hTDO ubiquitination and UPD. Our studies have thus provided novel mechanistic insights into the cellular regulation of hTDO degradation by its L-Trp substrate, which may have important implications for the role of this enzyme in human diseases. They also offer invaluable structural basis for future QM/MM studies to further refine the proposed ferryl-based dioxygenation mechanism.
Methods
Protein expression and purification. Expression of hTDO was performed as described elsewhere 4, 36 . To ensure homogeneity of the sample, the protein was oxidized with potassium ferricyanide and immediately loaded on a G25 column pre-equilibrated with 50 mM Tris (pH 7.4) and 150 mM NaCl. The protein collected was flash frozen and stored in − 80 °C until use.
Protein crystallization. The binary complex of hTDO was crystallized using the under-oil microbatch method under anaerobic conditions inside a glove box at 18 °C. 3 μ l of hTDO (45 mg/ml) in 50 mM Tris (pH 8.0), containing 150 mM NaCl and 10 mM L-Trp, was reduced with 2-fold molar excess of sodium dithionite. It was then mixed with 3-6 μ L of a precipitant solution, containing 50 mM sodium citrate (pH 5.6), 5% (w/v) PEG 3350, and 2% (w/v) Tacsimate (pH 5). Crystals were harvested after 3-5 days. The optical absorption spectra were taken to ensure the crystals were in a fully reduced deoxy state. Data collection and structure determination. X-ray diffraction data were collected at the X4A and X4C beamlines of National Synchrotron Light Source (NSLS). The diffraction images were processed with the program HKL 45 , and the data processing statistics are summarized in Table 1 . (c) In vitro ubiquitination of hTDO by three E2/E3 systems -G: Ubc7/gp78; H: Ubc7/Hrd1; C: UbcH5a/CHIP/ Hsc70/Hsp40. Experimental details of the ubiquitination reactions are described in ref. 43 . Color code wheel: Violet > indigo > blue > green > yellow > orange > red > . The comparative studies demonstrate that among the three complexes tested, the Ubc7/gp78 complex is the most efficient ubiquitination system for hTDO. (d) Structure of hTDO monomer showing the 13 ubiquitination K-sites (magenta) and the negatively charged glutamate residues (green) in the helix-loop-helix segment. Two additional K-sites identified in this study, K17 and K37, are not shown. K17 is not included in the expression construct, and K37 is located in a disordered region.
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The structure of hTDO was determined by the molecular replacement method, as implemented in the program MOLREP 46 , using the structure of XcTDO tetramer (PDB entry 2NW8) as the search model 25 . The atomic models were built with the program XtalView 47 , and the structure refinement was carried out with CNS 48 and PHENIX 49 . The refinement statistics are summarized in Table 1 . Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 5TI9 and 5TIA.
Mutagenesis. The mutants were made with the QuikChange kit (Stratagene) and verified by sequencing.
The mutant proteins were expressed and purified following the same protocol as that for the wild-type protein.
Stopped-flow measurements. The experiments were performed by either mixing deoxy ferrous enzymes (final concentration ~0.5 or 3 μ M) with air-saturated buffer or mixing ferric enzymes with buffer containing different concentrations of L-Trp in a π * 180 system from applied Photophysics Ltd (Leatherhead, Surrey, UK).
The deoxy ferrous enzyme was prepared by stoichiometrically titrating N 2 -purged ferric enzyme with dithionite. All the solutions were prepared in pH 8 Tris buffer (50 mM), containing 150 mM NaCl and a desired amount of Trp. The temperature was controlled at 25 °C by a circulating water bath (Neslab RTE-9DD). For steady-state activity measurements, the formation of the product, NFK, was monitored at 321 nm (ε = 3750 M −1 cm −1 ) as a function of time. The initial linear velocity of the reaction was plotted as a function of substrate concentration and fitted with the Michaelis-Menten equation using Origin 6.1 software (Microcal Software, Inc., MA, USA).
Isothermal titration calorimetry (ITC) measurements. The Trp affinities were measured in a Microcal
VP-ITC (Northhampton, MA) in an anaerobic glove box. The ITC was calibrated using the built-in electrical calibration check. The ferric WT hTDO solution (0.2 mM) in the reaction cell and the Trp solution (3.5 mM) in the syringe were prepared in the same buffer in ddH2O (pH 8 100 mM Tris containing 150 mM NaCl). All solutions were pre-purged with nitrogen gas, to avoid turnover. Following thermal equilibrium at 20 °C, an initial 600 s delay and a single 2.0 μ l titrant injection, 10 serial injections of 4 μ l, followed by 40 serial injection of 6 μ l Trp solution, were done at an interval of 300 s into the stirred sample cell (1.4 mL) containing the ferric hTDO complex at a stirring rate of 155 rpm. A reference power of 15 μ cal/s was used. The heat associated with each titration peak was integrated and plotted against the respective molar ratio of Trp/hTDO. Similar procedure was used for the measurement of the W208V/R211L mutant (0.1 mM), except that following thermal equilibrium at 20 °C, an initial 600 s delay and a single 2.0 μ l titrant injection, 47 serial injections of 6 μ l Trp solution were done at an interval of 450 s into the stirred sample cell. Data were analyzed using nonlinear least-squares curve fitting in Origin7.0 (OriginLab Corp., Northampton, MA) using the standard one-binding site model. DMEM containing 2.5 mM α MTrp, 5 mM cold methionine and cysteine, and further incubated for 0, 30, 60 and 90 min at 37 °C. The cells harvested at each time point were lysed in Cell-Signaling Lysis buffer, containing general protease and phosphatase inhibitors, and N-ethylmaleimide (10 mM) to inhibit deubiquitinases. The lysates were centrifuged at 10,000 g at 4 °C for 10 min to remove insoluble cell debris. The protein concentration was determined by the bicinchoninic assay (BCA). Lysate protein (200 μ g) was then diluted (1:4, v:v) in Dynabead pull-down buffer and mixed with Dynabeads (50 μ l). The mixture was incubated at 4 °C with rotation overnight. The Dynabeads-His 6 -tagged hTDO protein complexes were then collected using a magnetic stand and washed five times with Dynabead-washing buffer. The His 6 -tagged hTDO proteins were eluted by heating the complexes for 5 min in an SDS-PAGE sample-loading buffer (40 μ l, 62.5 mM pH 6.8 Tris buffer containing 25% (v/v) glycerol, 10% (w/v) SDS, 5% (v/v) β -mercaptoethanol and 0.01% (w/v) bromophenol blue). The radioactivity of a 10 μ l aliquot was monitored in 4 ml of Ecolume using a Beckman LS3801 liquid scintillation counter. The radioactivity of the eluates was used for the pulse-chase 35 S-TDO-degradation analysis. Another 30 μ l-aliquot of the eluate (containing parent TDO protein and its ubiquitinated species) was subjected to SDS-PAGE (4-15%). The gels were dried and subjected to fluorography with Typhoon scanning.
In vitro hTDO ubiquitination by 3 different E2/E3 Ub-ligase systems. Purified recombinant hTDO (400 pmol) was incubated in each of the three functionally reconstituted E2/E3 systems in a final volume of 50 μ l, and the reactions initiated with an ATP-regenerating system as described previously 43, 44, 50 . The reaction mixtures were incubated at 30 °C for 60 min. Aliquots (30 μ l) of each reaction mixture were then subjected to SDS-PAGE and Western immunoblotting analyses with subsequent 5-min exposure to electrochemiluminescent (ECL) substrate for pico-detection, as described 44, 50 . The film was developed and visualized using a Typhoon scanner in the chemiluminescence mode.
Identification of hTDO K-ubiquitination sites. Ubiquitinated hTDO proteins generated as described above were combined and precipitated with 2-volumes of ice-cold acetone at − 20 °C, overnight. The pellets were redissolved in 50 mM ammonium bicarbonate (ABC) solution containing 8 M urea and reduced with tris (2-carboxyethyl) phosphine (TCEP, 10 mM) and then alkylated with chloroacetamide (20 mM) at room temperature in the dark and diluted with the same ABC solution to a final concentration of < 2 M urea followed by a combined lysyl endoprotease C (Lys-C)/trypsin digestion with a 1:25 enzyme:protein mass ratio, at 37 °C for 16-18 h. The digested peptides were desalted and extracted with a Sep-Pak C18 classic cartridge (Waters Inc.) and subjected to anti-KGG antibody (PTMScan Ubiquitin Remnant Motif kit, Cell Signaling) pull-down to enrich the ubiquitinated peptides before LC-MS/MS analyses. Ubiquitinated samples were analyzed on an LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific) equipped with a nanoAcquity UPLC system (Waters). Peptides were resuspended in 0.1% formic acid and separated in an Easy-Spray column (Thermo, PepMap, C18, 3 μ m, 100 Å, 75 μ m × 15 cm) using a chromatographic system with a linear gradient from 2% solvent A (0.1% formic acid in water) to 35% solvent B (0.1% formic acid in acetonitrile) at 300 nL/min over 35 min. MS precursor spectra were measured in the Orbitrap from 300-2000 m/z at 30,000 resolving power, selected and dissociated by higher energy collisional dissociation (HCD) for MS/MS analyses as described 44, 50 . The MS/MS data were searched against the SwissProt database using the in-house Protein Prospector search engine (UCSF), with a concatenated database consisting of normal and randomized decoy databases. In addition to common modifications such as methionine oxidation and protein N-terminal acetylation, GlyGly (Uncleaved K), LeuArgGlyGly (Uncleaved K) modifications were considered for ubiquitination in the database search. False discovery rate (FDR) for ubiquitination was estimated to be 1% corresponding to the maximum expectation values of 0.01. Peptides with expectation values of 0.01 or less were accepted.
